Talk track

Key Messages

  • STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device is designed specifically for high-tension closures like the fascia.1-2
  • Overcomes the trade-offs associated with interrupted and continuous closure techniques with self anchoring technology, which provides multiple points of fixation along the suture line. This combines the strength and security of interrupted closure, with the efficiency of continuous closure3-7 with no knot-related complications such as increased risk of infection from bacterial attachment.
  • Incorporates antibacterial technology with triclosan coating, which has been shown to inhibit bacterial colonization of the suture for 11 days or more​.8
  • Aligns with recommendations by the CDC, ACS/Surgical Infection Society, and NICE guidelines, which all advise that triclosan-coated sutures should be used to reduce the risk of SSIs​.
  • A meta-analysis of 21 randomized controlled trials showed a 28% reduction in SSI risk with the use of triclosan-coated sutures​.14‡§

Detailed Talk Track

I understand you don’t currently use a barbed or knotless suture technique. You mentioned consistent tension and control with your sutures is important when closing the fascia. That’s where STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device can make a real difference. It’s designed specifically for high-tension closures like the fascia.1-2 Many surgeons have told me about the trade-offs that can come with traditional suture techniques. For example, interrupted closure can lead to inconsistent distribution of tension, knot related complications and can be time consuming. While the continuous closure technique can lead to a compromise in strength and security and a potential break in the suture.3-5 The STRATAFIX™ Knotless Tissue Control Devices overcomes these trade-offs with self anchoring technology which provides multiple points of fixation along the suture line, combining the strength and security of interrupted closure, with the efficiency of continuous closure6,7 – with no knot-related complications such as increased risk of infection from bacterial attachment. STRATAFIX™ Symmetric PDS™ Plus also incorporates antibacterial technology with triclosan coating, which has been shown to inhibit bacterial colonization of the suture for 11 days or more​.8 Using STRATAFIX™ Symmetric PDS™ Plus sutures aligns with recommendations by the CDC, ACS/Surgical Infection Society, and NICE guidelines, which all advise that triclosan-coated sutures should be used to reduce the risk of SSIs​.*†,9-13 In fact, a meta-analysis of 21 randomized controlled trials showed a 28% reduction in SSI risk with the use of triclosan-coated sutures​.14‡§

References

*CDC, WHO, ACS/SIS, NICE, and KRINKO guidelines on reducing the risk of surgical site infections are general to triclosan-coated sutures and are not specific to any one brand.
†All triclosan-coated sutures in these RCTs were Ethicon Plus Antibacterial Sutures (MONOCRYL™ Plus, VICRYL™ Plus, and PDS™ Plus).
‡In a meta-analysis of 21 RCTs, 6462 patients, 95% CI: (14, 40%), P<0.001
§All triclosan-coated sutures in these RCTs were Ethicon Plus Antibacterial Sutures (MONOCRYL™ Plus, VICRYL™ Plus, and PDS™ Plus)
1. 100326296: Time Zero Tissue Holding – Competitive Claims Comparisons for STRATAFIX Knotless Tissue Control Devices vs Various Products. 2015. Ethicon, Inc.
2. AST-2013-0056 Performance Testing of STRATAFIX Symmetric PDS Size2-0 suture device for Tissue Holding Strength with Multiple Incision Defects to Measure Gapping. Ethicon, Inc.
3. Sissener T. Suture patterns. Comp Anim. 2006;11:14-19.
4. Boutros S, Weinfeld AB, Friedman JD. Continuous versus interrupted suturing of
traumatic lacerations: a time, cost, and complication rate comparison. J Trauma Injury
Infect Crit Care. 2000;48(3):495-497.
5. Seiler CM, Bruckner T, Diener MK, et al. Interrupted or continuous slowly absorbable
sutures for closure of primary elective midline abdominal incisions: a multicenter
randomized trial (INSECT: ISRCTN24023541). Ann Surg. 2009;249(3):576-582.
6. Moran ME, Marsh C, Perrotti M. Bidirectional-barbed sutured knotless running anastomosis v classic Van Velthoven suturing in a model system. J Endourol. 2007;21(10):1175-1178.
7. Vakil JJ, O’Reilly MP, Sutter EG, Mears SC, Belko SM, Khanuja HS. Knee arthrotomy repair with a continuous barbed suture: a biomechanical study. J Arthroplasty. 2011;26(5):710-713.
8. Bhende S, Burkley D, Nawrocki J. In vivo and in vitro antibacterial efficacy of absorbable barbed poydioxanone monofilament tissue control device with triclosan. Surg Infect 2018; Volume 19 (4):430-437.
9. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection. JAMA Surg. 2017;152(8):784_791.
doi:10.1001_jamasurg. 2017.0904.
10. World Health Organization. Global Guidelines for the Prevention of Surgical Site Infection. https:__apps.who.int_iris_bitstream_handle_10665_250680_9789241549882-eng.pdf?sequence=8. Published November 2016. Accessed August 24, 2023
11. Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society:
Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2016;224(1):59_74.
12. National Institute for Health and Care Excellence (NICE) Guideline. Surgical site infections: prevention and treatment. NICE website. https:__www.nice.org.uk_guidance_ng125_chapter_Recommendations#closuremethods. Accessed August 24, 2023.
13. Prevention of postoperative wound infections. Recommendation of the Committee for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute. Bundesgesundheitsbl. 2018; 61(4):448_473
14. de Jonge SW, Atema JJ, Solomkin JS, Boermeester MA. Meta-analysis and trial sequential analysis of triclosan-coated sutures for the prevention of surgical site infection. Brit J Surg. 2017;ePub-DOI: 10.1002_bjs.10445.

CONFIDENTIAL. FOR INTERNAL USE ONLY. NOT FOR USE WITH ANY CUSTOMER OR FOR EXTERNAL DISTRIBUTION.

Close

Click for assets
STRATAFIX™ Symmetric resources